Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Entrada Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 110
- +9 vs. Q4 2024
- Shares held
- 30.2M
- −307.7K (−1.0%) vs. Q4 2024
- Total value
- $274.5M
- −$253.7M (−48.0%) vs. Q4 2024
- New holders
- 20
- 28 more added
- Sold out
- 11
- 42 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 128 | $214.4M |
| Q1 2026 | 119 | $321.4M |
| Q4 2025 | 113 | $251.0M |
| Q3 2025 | 116 | $164.8M |
| Q2 2025 | 107 | $198.8M |
| Q1 2025 | 110 | $274.5M |
| Q4 2024 | 102 | $529.8M |
| Q3 2024 | 97 | $481.1M |
| Q2 2024 | 84 | $423.1M |
| Q1 2024 | 77 | $368.8M |
| Q4 2023 | 62 | $396.6M |
| Q3 2023 | 55 | $411.4M |
| Q2 2023 | 56 | $389.9M |
| Q1 2023 | 53 | $361.0M |
| Q4 2022 | 47 | $334.2M |
| Q3 2022 | 33 | $386.4M |
| Q2 2022 | 38 | $301.8M |
| Q1 2022 | 48 | $242.8M |
| Q4 2021 | 46 | $433.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| StepStone Group LP | 761,277 | $6.88M | 7.07% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,053,314 | $9.52M | 0.00% | +21,488+2.1% | Added |
| FMR LLC | 1,239,811 | $11.2M | 0.00% | −160,105−11.4% | Reduced |
| Vanguard Group Inc | 1,575,594 | $14.2M | 0.00% | +111,357+7.6% | Added |
| BlackRock, Inc. | 1,990,853 | $18.0M | 0.00% | +16,401+0.8% | Added |
| Janus Henderson Group PLC | 2,121,654 | $20.3M | 0.01% | +41,287+2.0% | Added |
| Price T Rowe Associates Inc | 2,736,767 | $24.7M | 0.00% | −166,258−5.7% | Reduced |
| MPM Asset Management LLC | 4,381,062 | $39.6M | 57.04% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 4,408,379 | $39.9M | 15.07% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 4,865,819 | $44.0M | 0.49% | 00.0% | Unchanged |
| BayBridge Capital Group, LLC | 0 | $0 | 0.00% | −28,563−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −16,453−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −14,036−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −14,030−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −12,538−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −12,527−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −3,924−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −407−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |